Endocrinology · Primary Ovarian Insufficiency

Fertility, Family Building, and Contraception

At a Glance

While POI makes getting pregnant difficult, 5-10% of women experience spontaneous pregnancy. For those wanting to conceive, donor egg IVF is the most successful medical option. If you do not want to get pregnant, you must use contraception, as HRT does not prevent pregnancy.

Navigating the world of fertility with Primary Ovarian Insufficiency (POI) can feel like a series of contradictions. While the diagnosis means your ovaries are not functioning as they should, it does not always mean your chance of pregnancy is zero. Understanding the biological reality, the success of modern interventions, and the need for proactive family planning is essential ^[1]^[2].

The Paradox of Spontaneous Pregnancy

A diagnosis of POI can be devastating, particularly for those hoping to start or grow a family. However, unlike permanent menopause, POI can be intermittent.

The 5-10% Chance: Research shows that approximately 5% to 10% of women with POI will experience a spontaneous pregnancy after their diagnosis ^[2]^[3]. This happens because the ovaries may occasionally and unpredictably release an egg, even after months of no periods ^[4].
The Contraception Need: Because this “spontaneous resumption” is unpredictable, it is a medical myth that you cannot get pregnant with POI. If you do not wish to become pregnant, you must use contraception. It is critical to know that Hormone Replacement Therapy (HRT) is not a contraceptive and will not prevent pregnancy ^[2].
Integrating Contraception with HRT: A highly effective strategy is combining a hormonal IUD (like Mirena, which provides both localized contraception and the required progestin for your uterus) alongside an estrogen patch or gel. Alternatively, combined oral contraceptives can be used ^[2].

Biological Family Building Options

For many with POI, achieving a pregnancy requires medical assistance. The options range from established standards to cutting-edge research.

The Gold Standard: Donor Eggs and Embryos

Using eggs from a donor (oocyte donation) is the most successful way for women with POI to achieve a biological pregnancy ^[5].

Success Rates: Success depends largely on the age of the egg donor, not the age of the recipient.
Embryo Donation: This involve receiving a donated embryo (often from another couple’s successful IVF journey). It is a highly effective option, with live birth rates reported around 31.9% per transfer ^[6]^[7].
Medical Considerations: It is important to be aware that donor egg pregnancies carry a higher risk of preeclampsia and hypertensive disorders compared to natural conception ^[8]^[9].

Autologous IVF and Experimental Procedures

Autologous IVF: Using your own eggs in IVF is rarely successful in POI cases because the ovarian reserve is severely depleted. Success rates are often less than 5% per cycle ^[10].
In Vitro Activation (IVA): This is a new, experimental procedure where ovarian tissue is surgically removed, “activated” in a lab to wake up dormant follicles, and then re-implanted ^[11]^[12]. While some babies have been born using this method, it is not yet considered a standard treatment and is currently only available in specialized research centers ^[13]^[14].

Non-Biological Paths and Support

Building a family through adoption or foster-to-adopt are paths many choose. These options provide the opportunity to parent without the medical risks of pregnancy, though they come with their own unique legal and emotional journeys ^[15]^[16].

Regardless of the path you choose, the emotional weight of a POI diagnosis is significant. Seeking specialized counseling can help you and your partner process the psychosocial challenges of third-party reproduction or the decision to pursue non-biological family building ^[17]^[18].

Common questions in this guide

Can I still get pregnant naturally with POI?

Yes, it is possible. About 5% to 10% of women with Primary Ovarian Insufficiency experience a spontaneous pregnancy. This happens because the ovaries may occasionally and unpredictably release an egg, even after months of no periods.

Does hormone replacement therapy prevent pregnancy?

No, Hormone Replacement Therapy (HRT) is not a contraceptive. Because spontaneous ovulation can still occur unpredictably with POI, you must use a reliable form of birth control, such as a hormonal IUD, if you do not wish to become pregnant.

What is the most successful fertility treatment for POI?

The most successful way for women with POI to achieve a biological pregnancy is through IVF using donor eggs or donated embryos. Success rates for this method are high and depend largely on the age of the egg donor rather than the recipient.

Can I use my own eggs for IVF if I have POI?

Using your own eggs for IVF is rarely successful with POI due to severely depleted ovarian reserve. Success rates using autologous eggs are typically less than 5% per cycle.

What is In Vitro Activation (IVA)?

In Vitro Activation is an experimental procedure where ovarian tissue is surgically removed, activated in a lab to stimulate dormant eggs, and re-implanted. It is not yet a standard treatment and is currently only available at specialized research centers.

Curated prompts to bring to your next appointment.

1.What is my current AMH level and antral follicle count, and what do they honestly mean for my chances of autologous IVF success?
2.If we pursue donor eggs, what specific cardiovascular and blood pressure screenings do I need given the higher risk of preeclampsia?
3.Is in vitro activation (IVA) an option at this clinic, or is it still considered experimental and performed only in research settings?
4.If I am not ready to conceive yet, should we look at combining an estrogen patch with a hormonal IUD to prevent an unplanned pregnancy?
5.Can you refer me to a fertility counselor who specializes in the psychosocial aspects of third-party reproduction?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (18)

1
Autoimmune Diseases in Patients with Premature Ovarian Insufficiency-Our Current State of Knowledge.
Szeliga A, Calik-Ksepka A, Maciejewska-Jeske M, et al.
International journal of molecular sciences 2021; (22(5)) doi:10.3390/ijms22052594.
PMID: 33807517
2
Committee Opinion No. 698: Hormone Therapy in Primary Ovarian Insufficiency.
Obstetrics and gynecology 2017; (129(5)):e134-e141 doi:10.1097/AOG.0000000000002044.
PMID: 28426619
3
Spontaneous pregnancy after tracking ovulation during menstruation: A case report of a woman with premature ovarian insufficiency and repeated failure of in vitro fertilization.
He Y, Wang W, Wu C, et al.
Frontiers in medicine 2022; (9()):994674 doi:10.3389/fmed.2022.994674.
PMID: 36569135
4
Successful Spontaneous Pregnancy and Live Birth in a Woman With Premature Ovarian Insufficiency and 10 Years of Amenorrhea: A Case Report.
Gu Y, Xu Y
Frontiers in medicine 2020; (7()):18 doi:10.3389/fmed.2020.00018.
PMID: 32118005
5
Live birth after oocyte donation in women with Turner syndrome compared with other causes of premature ovarian insufficiency: a retrospective cohort study.
Saignes H, Romain-Scelle N, Labrune E, et al.
Journal of assisted reproduction and genetics 2026; doi:10.1007/s10815-026-03906-1.
PMID: 42183950
6
Outcomes and efficiency of embryo donation: an 8-year retrospective analysis from a Belgian ART centre.
Johnson S, Ancion M, Raick D, et al.
Journal of assisted reproduction and genetics 2026; (43(6)):1819-1829 doi:10.1007/s10815-026-03859-5.
PMID: 42018220
7
Revisiting the early days of oocyte and embryo donation: relevance to contemporary clinical practice.
Sauer MV
Fertility and sterility 2018; (110(6)):981-987 doi:10.1016/j.fertnstert.2018.09.005.
PMID: 30396565
8
Pre-eclampsia in pregnancies resulting from oocyte donation, natural conception or IVF: a systematic review and meta-analysis.
Keukens A, van Wely M, van der Meulen C, Mochtar MH
Human reproduction (Oxford, England) 2022; (37(3)):586-599 doi:10.1093/humrep/deab267.
PMID: 34931678
9
Is the risk of preeclampsia higher in donor oocyte pregnancies? A systematic review and meta-analysis.
Schwarze JE, Borda P, Vásquez P, et al.
JBRA assisted reproduction 2018; (22(1)):15-19 doi:10.5935/1518-0557.20180001.
PMID: 29266893
10
Successful Pregnancy in a Poor Responder: Natural In Vitro Fertilization, Menopause Treatment With Oral Contraceptives, and Anti-Müllerian Hormone as a Predictor.
Voros C, Mavrogianni D, Stavros S, et al.
Cureus 2024; (16(11)):e74650 doi:10.7759/cureus.74650.
PMID: 39735088
11
Biological therapies for premature ovarian insufficiency: what is the evidence?
Moustaki M, Kontogeorgi A, Tsangkalova G, et al.
Frontiers in reproductive health 2023; (5()):1194575 doi:10.3389/frph.2023.1194575.
PMID: 37744287
12
Ovarian Fragmentation and AKT Stimulation for Expansion of Fertile Lifespan.
Vo KCT, Kawamura K
Frontiers in reproductive health 2021; (3()):636771 doi:10.3389/frph.2021.636771.
PMID: 36304045
13
Drug-free in vitro activation of ovarian follicles and fresh tissue autotransplantation in patients with poor ovarian response and premature ovarian insufficiency.
Grin L, Berkovitz-Shperling R, Goldstein G, et al.
F&S science 2025; (6(3)):303-311 doi:10.1016/j.xfss.2025.04.002.
PMID: 40315958
14
In vitro activation of ovarian cortex and autologous transplantation: A novel approach to primary ovarian insufficiency and diminished ovarian reserve.
Devenutto L, Quintana R, Quintana T
Human reproduction open 2020; (2020(4)):hoaa046 doi:10.1093/hropen/hoaa046.
PMID: 33225075
15
Experiences of Mothers Receiving Donated Embryos.
Zandi M, Dabaghi S, Salimi Akinabadi A, et al.
Iranian journal of nursing and midwifery research 2023; (28(5)):559-568 doi:10.4103/ijnmr.IJNMR_462_20.
PMID: 37869689
16
Formal and informal support and counselling for embryo donation and receipt: An Australian qualitative study.
Riggs DW, Bartholomaeus C
Health & social care in the community 2020; (28(3)):950-957 doi:10.1111/hsc.12926.
PMID: 31833160
17
Psychosocial impacts of spontaneous and medically induced premature ovarian insufficiency and early menopause: A systematic review and thematic synthesis of qualitative studies.
Minchin E, Laidsaar-Powell R, Kirsten L, et al.
Maturitas 2026; (209()):108971 doi:10.1016/j.maturitas.2026.108971.
PMID: 42102512
18
Primary Amenorrhea and Premature Ovarian Insufficiency.
Yatsenko SA, Witchel SF, Gordon CM
Endocrinology and metabolism clinics of North America 2024; (53(2)):293-305 doi:10.1016/j.ecl.2024.01.009.
PMID: 38677871

This content is for informational purposes only and does not substitute for professional medical advice. Always consult your reproductive endocrinologist or OB/GYN regarding your specific fertility and family-planning options.

Get notified when new evidence is published on premature menopause.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents